HDDC3 Inhibitors
HDDC3 inhibitors represent a class of chemical compounds specifically designed to impede the function of the Host Cell Factor C3 (HDDC3) protein. HDDC3, a protein implicated in various cellular processes, plays a critical role in the modulation of gene expression by interacting with host cell factors. Inhibitors targeting HDDC3 are characterized by their ability to bind to the active or allosteric sites of the protein, thereby preventing its interaction with other proteins or DNA sequences it would typically regulate. These compounds achieve their inhibitory effect by altering the conformational state of HDDC3, which can impede its ability to participate in the assembly of transcriptional complexes. The exact mechanisms of these inhibitors are diverse, reflecting the multitude of ways in which the HDDC3 function can be disrupted. Some inhibitors may mimic the natural substrates or cofactors of HDDC3, competitively blocking their binding sites, while others might bind to distinct sites, inducing structural changes that reduce the protein's functional activity.
The spectrum of HDDC3 inhibitors encompasses molecules that affect different aspects of the protein's operation, including its stability, its association with other cellular components, and its enzymatic activity, if any. These inhibitors are the product of rational drug design, where the three-dimensional structure of HDDC3 is used to identify potential binding pockets and to develop molecules that can effectively occupy these spaces. The specificity of HDDC3 inhibitors is crucial, as they must selectively interact with HDDC3 without affecting other proteins with similar structures or functions. This specificity is achieved through a meticulous optimization process, where chemical groups are added or modified to enhance the affinity and selectivity of the inhibitors for HDDC3. The biochemical pathways involving HDDC3 are complex, and the inhibitors are engineered to ensure that their interaction with the protein leads to a precise and predictable decrease in its functional activity, which is vital for studying the protein's role in cellular processes without introducing widespread disruption to the cell's overall function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases, known for its ability to inhibit Protein Kinase C (PKC). PKC plays a critical role in phosphorylation and activation of many proteins, including HDDC3. By inhibiting PKC, staurosporine indirectly leads to a reduction in the phosphorylation and subsequent activation of HDDC3. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of phosphoinositide 3-kinases (PI3Ks). PI3Ks are upstream of the Akt signaling pathway which could be implicated in the activation of HDDC3 by phosphorylation. Inhibition of PI3K by LY294002 would lead to decreased Akt activity, which in turn could result in reduced activation of HDDC3. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor which can downregulate protein synthesis. Since mTOR is a central regulator of cell growth and proliferation, its inhibition by rapamycin could result in decreased levels of proteins, potentially including HDDC3, by reducing overall protein synthesis. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a specific inhibitor of the MAP kinase kinase (MEK), which is part of the MAPK/ERK pathway. This pathway is involved in the regulation of a variety of cellular processes, including growth and differentiation, which may involve HDDC3. Inhibition of MEK by PD98059 would prevent the activation of ERK and potentially decrease the activity of HDDC3. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase, which is involved in stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) signaling pathways. HDDC3 activity could be modulated by these stress-related pathways, so inhibition of p38 by SB203580 could lead to decreased functional activity of HDDC3. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of PI3K. Similar to LY294002, it reduces Akt signaling, and given the possible regulatory relationship between the PI3K/Akt pathway and HDDC3, wortmannin would likely lead to a decrease in HDDC3 activation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which is part of the MAPK signaling pathways. JNK is implicated in the control of various cellular processes, which may include the functionality of HDDC3. Inhibition of JNK by SP600125 could result in reduced activity of HDDC3. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of both MEK1 and MEK2. By blocking MEK activity, U0126 can inhibit the ERK pathway, which may be involved in regulating HDDC3 activity. Thus, U0126 could contribute to a decrease in the functional activity of HDDC3. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is a selective inhibitor of Src family kinases. The Src family is involved in various signaling pathways that regulate cellular processes such as proliferation and differentiation, potentially affecting HDDC3. Inhibition by PP2 might lead to reduced HDDC3 activity through these pathways. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of the Rho-associated protein kinase (ROCK). ROCK is involved in the regulation of the actin cytoskeleton and motility, which may be critical for the proper localization and function of HDDC3. Inhibition by Y-27632 could impair the functional activity of HDDC3. | ||||||